
AIRA is building the new era of clinical development with a unified AI platform for trial design and protocol development. The platform enables biopharma teams to collaborate with expert-level AI thought partners across clinical, regulatory, statistical strategy, and medical writing domains. AIRA orchestrates 100+ custom-trained models and algorithms to support the full study design lifecycle. Biopharma companies in the U.S. use AIRA to shorten timelines by months and save hundreds of thousands of dollars per study - accelerating programs and helping therapies reach patients sooner and safer.
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.